INVIDA to restart hexamethylene diamine plant in Canada


Release time:

2024-07-30

Invitica, one of the world's largest integrated producers of chemical intermediates, polymers and fibers, announced plans to invest approximately C $23 million (US $17 million) to reactivate its hexamethylene diamine (HMD) assets at its Maitland plant in Ontario, Canada. Hexanediamine is a key ingredient in the production of nylon 6,6, a high-performance polymer that can be used in a variety of applications such as automotive, industrial, apparel and consumer products. "We are proud of our 71-year history of operating in Maitland communities. As we celebrate the past, we look forward to continuing to invest and innovate in our efforts to improve our competitiveness in the future," said Matt Murton, Invitica Canada's Maitland Plant Manager in Ontario." After approval by the regulatory authorities, the project can start construction, and the hexamethylenediamine plant will be put into operation in the first quarter of 2025.

Invitica, one of the world's largest integrated producers of chemical intermediates, polymers and fibers, announced plans to invest approximately C $23 million (US $17 million) to reactivate its hexamethylene diamine (HMD) assets at its Maitland plant in Ontario, Canada.

 

Hexanediamine is a key ingredient in the production of nylon 6,6, a high-performance polymer that can be used in a variety of applications such as automotive, industrial, apparel and consumer products.

 

"We are proud of our 71-year history of operating in Maitland communities. As we celebrate the past, we look forward to continuing to invest and innovate in our efforts to improve our competitiveness in the future," said Matt Murton, Invitica Canada's Maitland Plant Manager in Ontario."

 

After approval by the regulatory authorities, the project can start construction, and the hexamethylenediamine plant will be put into operation in the first quarter of 2025.

Key words:

Titanium dioxide-rutile | titanium dioxide-anatase | environmental protection-flame retardant | quality-filler

You can also learn more about Tianke dynamic

2024/07/31

Alkalinity degradation agent discolors the solution

An alkalinity-degrading agent is a chemical that can cause a color change in a solution. After the alkalinity degradation agent is added to the solution, its molecules will react with the alkaline substance in the solution, resulting in a change in the acidity and alkalinity of the solution, which in turn causes the color of the solution to change.

2024/07/31

Alkalinity regulator

Alkalinity regulator is also called medium regulator, pH regulator. One of the regulators in flotation reagents. It is used to adjust the pH of the pulp to facilitate the action of other agents with the mineral surface and eliminate the influence of harmful ions in flotation. Such as lime, sodium hydroxide, sulfuric acid, sodium carbonate, etc.

2024/07/31

Industrial grade anhydrous sodium sulfite has those

Technical grade anhydrous sodium sulfite is a colorless crystalline solid, chemical formula Na2S2O5. It is an important chemical raw material and is widely used in industry. There are mainly the following types of anhydrous sodium sulfite.

2024/07/31

DuPont completes acquisition of Donatelle plastics company

DuPont announced on July 29, 2024 that it had completed its previously announced acquisition of Donatelle Plastics ("Donatelle"). Jon Kemp, President of DuPont Electronics and Industrial (E & I), said, "We welcome the talented Donatelle team to DuPont. Donatelle have best-in-class advanced injection molding manufacturing capabilities and decades-long relationships with large medical device manufacturer customers, and we are pleased to have the Healthcare product line in the Electronics and Industrial Division." Donatelle have more than 400 employees and are now part of DuPont's Industrial Solutions business. Donatelle acquisition brings a range of advanced technologies and capabilities, including medical device injection molding, liquid silicone rubber processing, precision machining, equipment assembly and tool manufacturing, to complement existing businesses. Donatelle has strong financial growth capabilities in attractive therapeutic areas such as electrophysiology, drug delivery, diagnostics, cardiac rhythm management, neurostimulation and limb orthopedics.